Navigation Links


Additional at Biology News

DDT-resistant insects have additional genetic advantage that helps resistance spread

Insects that can withstand the powerful pesticide DDT that was banned in the 1970s have an additional genetic advantage over their rivals that has helped them spread across the globe ever since, according to research published in Current Biology tomorrow (9 August 2005). This discovery overturns current theories that resistance to pesticides burdens insects with a genetic disadvantage tha...
Additional at Biology Products
Additional at Biology Technology

PCR Grade Deoxynucleotides Additional power to perfect your PCR experiments

Deoxynucleotides are vital components in amplification reactions, and the purityof these reagents significantly influences the results of your experiments. Roche Applied Science developed a new manufacturing and purificationprocess for...

Senate Democrats strip additional Act 255 funding from budget

The caucus voted to delete provisions that would increase the maximum annual amount of...

Small Tree receives additional angel funding

The company makes network drivers and other products for Ap...

API Releases New Software, Acquires Additional Contracts

Healthcare organizations can increase their productivity and be more responsive to the needs of their employees and thus improve the quality of the care they provide as a result of two new products from , a Hartford, Wis.-based software company. API Software announced Tuesday the availability of the companys wireless Emp...
Additional at Medicine News

Additional Radiotheraphy for Breast Cancer

Research says that giving extra radiotherapy to patients with early breast cancer significantly reduces the risk of cancer recurring in the breast. //The results were so clear that clinical practice should be changed immediately, particularly for younger women. Nearly five thousand patients took part in the study. The majority of patients had undergone complete removal of their tumor....

Adding An Additional Drug May Help Patients With Glaucoma

Adding the drug latanoprost, also known as Xalatan, to conventional drugs used to treat the most common form of glaucoma can help reduce dangerous pressure // in the eye that leads to blindness. Researchers conducted their study among 380 patients with open-angle glaucoma or another form of glaucoma known as exfoliation glaucoma who had originally used the drug in another three-year stud...

Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals

In order to meet the growing demand for medical staff, it has been proposed to extend the Medicare payments to other health professionals. The role, currently played by nurses, podiatrist surgeons and other allied health professionals would be further extended to accomodate them into vacant postitions. // It has led to mixed reactions from doctors and other health professionals. The pro...

No More Additional Cases of Mad Cow Disease in Canada

Mad cow disease or bovine spongiform encephalopathy (BSE) is the condition in which there is extensive wasting of the brain among the cattle. It is very fatal.// The Canadian Food Inspection Agency (CFIA) started its investigation when the fourth cow was tested positive for this disease. The cow was home-grown and six-years old. The results of the investigation were that there...

NACO to Introduce 400 Additional AIDS/HIV Screening Centers

New Delhi :The National AIDS Control Organization (NACO) is due to introduce 400 additional testing centers in several States across the country mainly in the central and northern parts of India.// With the opening of the additional testing centers, the number of centers will total 1150. Nearly 5.2 million people have been found combating HIV/AIDS, according to results from the annual...

More>>

Additional at Medicine Products
Additional at Medicine Technology

Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- PortolaPharmaceuticals, Inc. announced today that it will present clinicaland preclinical data on its oral Factor Xa inhibitor and on itsintravenous and oral ADP receptor antagonist at the XXI Congress ofthe International Society of Thrombosis and Haemostasis (ISTH) inGeneva, Switzerland on July 6 through July 12, 2007. The EXPERT...

Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

SOUTH SAN FRANCISCO, CA June 28, 2007 - Cytokinetics,Incorporated (Nasdaq: CYTK) announced results from the analyses ofthree Phase II clinical trials of ispinesib administered asmonotherapy, one in patients with hepatocellular cancer, one inpatients with melanoma, and one in patients with hormone-refractoryprostate cancer. I...

Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 14, 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX) today announced the presentation ofadditional data related to its immuno-inflammatory productcandidates, CRx-102 and CRx-139, at the European League AgainstRheumatism (EULAR) Annual Congress of Rheumatology meeting, June13-16, 2007 in Barcelona, Spain. In a poster entitled "Inhibition...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

* Statistically significant reduction in sedation during theearly post-operative period compared to morphine * Statistically significant reduction in nausea in the femalepatient population compared to morphine Cambridge, UK, 8th June 2007 - CeNeS Pharmaceuticals plc (AIM:CEN), the Cambridge based biopharmaceutical company, announcesadditional data from post-hoc analysis of th...

Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 6, 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX), today announced that data from itsrandomized, blinded, placebo-controlled phase 2 clinical trials ofCRx-102 in patients with osteoarthritis (OA) and rheumatoidarthritis (RA) will be featured at the European League againstRheumatism (EULAR) Annual Congress of Rheumatology meeting, June13-16, 2007 in Bar...

More>>

Other TagshitsthoughtsTenTenTenTenTenTenTenTen
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
(Date:10/9/2008)...Work by researchers at North Carolina State Univer...e crabs grown and harvested from freshwater ponds,...t worry, researchers say, because the pond-raised ...brethren. , North Carolina,s native blue crab po... Dave Eggleston, director of NC State,s Center for...
(Date:10/9/2008)...BOULDER--Wildfires can boost ozone pollution to le...dy concludes. The research, by scientists at the N...cused on California wildfires in 2007, finding tha...ke to unhealthy levels across a broad area, includ...g Nevada. , The study was published today in Ge...
(Date:10/9/2008)...Nanotechnologies can be used to develop sustainabl...s of fossil fuels as they are gradually phased out...s coming closer to reality as new technologies suc...SCs) emerge with great promise for capturing or st...icient catalysts for energy-saving industrial proc...
(Date:10/9/2008)..., You can,t raise a finger without your brai...red out another reason that usually works so well...., to the muscle cell to tell it what to do. To get...tor. Oddly, the unstable protein rapsyn is respons...ositioned to catch the message. , Medical Colleg...
Breaking Biology News(10 mins):Turning freshwater farm ponds into crab farms 2Wildfires cause ozone pollution to violate health standards, new study shows 2Wildfires cause ozone pollution to violate health standards, new study shows 3Europe rallies behind nanotechnology to wean world from fossil fuels 2Europe rallies behind nanotechnology to wean world from fossil fuels 3Europe rallies behind nanotechnology to wean world from fossil fuels 4Stabilizing force for good communication between neurons and muscle cells found 2Hurricane Ike tracked by ESAs Envisat 4832 1Hurricane Ike tracked by ESAs Envisat 4832 2Wolters Kluwer Health Appoints Scott Lubeck Vice President Technology of its Professional 26 Education Unit 26312 1Wolters Kluwer Health Appoints Scott Lubeck Vice President Technology of its Professional 26 Education Unit 26312 2MEMC Provides Update on Hurricane Ike 7632 1MEMC Provides Update on Hurricane Ike 7632 2MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 7631 1MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 7631 2MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 7631 3
Other Contentstolerancetolerancetolerancetolerancetolerancetolerancetoleranceinducedinducedinducedinducedinducedinducedinducedinducedinducedinducedmarginmarginmarginmarginmarginmarginmargincleancleancleancleancleancleancleancleancarecarecarecarecarecarecarecarecomputerscomputerscomputers